Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 多克隆抗體
  4. RARRES3 Antibody

RARRES3 Antibody

  • 中文名稱：
    RARRES3兔多克隆抗體
  • 貨號(hào)：
    CSB-PA911568
  • 規(guī)格：
    ￥1100
  • 圖片：
    • The image on the left is immunohistochemistry of paraffin-embedded Human colon cancer tissue using CSB-PA911568(RARRES3 Antibody) at dilution 1/25, on the right is treated with fusion protein. (Original magnification: ×200)
  • 其他：

產(chǎn)品詳情

  • Uniprot No.：
  • 基因名：
    RARRES3
  • 別名：
    HRASLS4 antibody; MGC8906 antibody; RAR responsive protein TIG3 antibody; RAR-responsive protein TIG3 antibody; RARRES3 antibody; Retinic acid inducible gene 1 antibody; Retinoic acid receptor responder (tazarotene induced) 3 antibody; Retinoic acid receptor responder protein 3 antibody; Retinoid inducible gene 1 protein antibody; Retinoid-inducible gene 1 protein antibody; RIG 1 antibody; rig1 antibody; Tazarotene induced gene 3 protein antibody; Tazarotene-induced gene 3 protein antibody; TIG 3 antibody; TIG3 antibody; TIG3_HUMAN antibody
  • 宿主：
    Rabbit
  • 反應(yīng)種屬：
    Human
  • 免疫原：
    Fusion protein of Human RARRES3
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標(biāo)記方式：
    Non-conjugated
  • 抗體亞型：
    IgG
  • 純化方式：
    Antigen affinity purification
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
  • 產(chǎn)品提供形式：
    Liquid
  • 應(yīng)用范圍：
    ELISA,IHC
  • 推薦稀釋比：
    Application Recommended Dilution
    ELISA 1:2000-1:5000
    IHC 1:25-1:100
  • Protocols：
  • 儲(chǔ)存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 功能：
    Exhibits both phospholipase A1/2 and acyltransferase activities. Shows phospholipase A1 (PLA1) and A2 (PLA2), catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids. For most substrates, PLA1 activity is much higher than PLA2 activity. Shows O-acyltransferase activity, catalyzing the transfer of a fatty acyl group from glycerophospholipid to the hydroxyl group of lysophospholipid. Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC) and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE), forming N-acylphosphatidylethanolamine (NAPE), which serves as precursor for N-acylethanolamines (NAEs). Promotes keratinocyte differentiation via activation of TGM1.
  • 基因功能參考文獻(xiàn)：
    1. RIG-I and MDA5 receptor sensing of host non-coding RNAs facilitates the cell-intrinsic immune response to Kaposi's sarcoma-associated herpesvirus infection. PMID: 30451863
    2. we observed frameshift mutations of RARRES3 in 11 cases of colorectal cancer PMID: 29496306
    3. Data demonstrate that RIG-1 is activated after mitochondrial SUMOylation by MAPL which is an essential process for the mitochondrial antiviral signaling response. PMID: 28273895
    4. Low RIG1 expression is associated with Arenaviral infections. PMID: 29669840
    5. Conclusively, these data demonstrate the MCPIP1 contributes to attenuate influenza A virus-induced host antiviral response by suppressing RIG-I expression. PMID: 28892164
    6. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts. PMID: 28560754
    7. Identified the tumor suppressor RARRES3 as a critical target of G9a. Epigenetic silencing of RARRES3 contributed to the tumor-promoting function of G9a PMID: 28532996
    8. Results provide evidence that RIG-I as an essential mediator for influenza A virus-induced COX-2 expression. PMID: 27265729
    9. perifascicular pattern of RIG-I expression supports the diagnosis of dermatomyositis PMID: 28738907
    10. The current study establishes that hypoxia can profoundly influence the inducible RIG-I protein expression in malignant cells of both human and murine origin, whereas this phenomenon was not identified in nonmalignant cell lines or primary cells. PMID: 28468914
    11. our study demonstrates that the novel pathway lncRNA Ftx/miR-545/RIG-I promotes hepatocellular carcinoma development PMID: 26992218
    12. this review describes antiviral activities of RIG-I against influenza viruses (standing on three legs) PMID: 27318973
    13. Study uncovered a novel aspect of Rig-I in monitoring gut microbiota through regulating IgA and IL6-STAT3-dependent Reg3gamma pathway. Besides, Rig-I loss could also promote colorectal cancer progression both in the presence and absence of intestinal bacteria. PMID: 28057020
    14. a novel mechanism of pattern recognition receptor modulation by HCV and suggests a biological function of the HCV alternate reading frame in the modulation of host innate immunity PMID: 27404108
    15. this study indicated that increased expression of TIG3 in primary glioblastoma is a novel biomarker for predicting poor outcome of patients. We then hypothesize that TIG3 may function in a different pattern in glioblastoma PMID: 28639915
    16. Foot-and-mouth disease virus Viroporin 2B antagonizes RIG-I-mediated antiviral effects by inhibition of its protein expression. PMID: 27707918
    17. Overexpression of TIG3 suppresses tumor growth in hepatocellular carcinoma PMID: 26951515
    18. miR-34a is an antioncogene in multiple tumors, in this study, RIG-I and miR-34a suppressed cell growth, proliferation, migration, and invasion in cervical cancer cells in vitro. miR-34a was validated as a new regulator of RIG-I by binding to its 3' untranslated region and upregulating its expression level. PMID: 26910120
    19. TRIM25 plays an additional role in RIG-I/MDA5 signaling other than RIG-I ubiquitination via activation of NF-kappaB. PMID: 26299329
    20. These observations highlight the importance of RIG-I signaling in anti-HIV innate immunity in macrophages, which may be beneficial for the treatment of HIV and aid in the understanding of the neuropathogenesis of HAND. PMID: 26535695
    21. Gal1 and gal3 regulate the inflammatory response in airway epithelial cells exposed to microbial neuraminidase by modulating the expression of SOCS1 and RIG1. PMID: 26355912
    22. findings provide a new insight into the molecular link between p53, protein acylation and Wnt/beta-catenin signaling whereby RARRES3 plays a pivotal role in modulating the acylation status of signaling proteins. PMID: 25361079
    23. During Crimean-Congo hemorrhagic fever virus infection, RIG-I mediated a type I interferon response via MAVS. PMID: 26223644
    24. the flexible main loop of H-REV107, but not that of TIG3, is critical for its NTD to modulate its CTD in inducing cell death. PMID: 25871522
    25. Viral pseudo-enzymes activate RIG-I via deamidation to evade cytokine production. PMID: 25752576
    26. critical for the initiation of IRF-3 phosphorylation, dimerization and downstream gene expression during antiviral innate immune response PMID: 24800889
    27. RARRES3 downregulation engages metastasis-initiating capabilities by facilitating adhesion of the tumor cells to the lung parenchyma. PMID: 24867881
    28. MiR-545 exerts its effects in pancreatic ductal adenocarcinoma by directly targeting RIG-1 PMID: 25315416
    29. These findings argue that TIG3 is involved in the control of keratinocyte differentiation and that loss of TIG3 in transformed cells contributes to the malignant phenotype. PMID: 24599174
    30. We show that the C-terminal hydrophobic domain targets intact TIG3 to the plasma membrane, but when isolated as an independent element localizes at the mitochondria and a segment of the N-terminal hydrophilic region targets the centrosome. PMID: 24401997
    31. Low RIG1 expression is associated with testis cancer. PMID: 22960220
    32. RIG1 gene is a downstream target of p53 in cancer cell lines PMID: 22616991
    33. Data suggest that pericentrosomal localization of TIG3 is a key event that results in microtubule and microfilament redistribution and pericentrosomal organelle clustering and that leads to cancer cell apoptosis. PMID: 21858038
    34. We conclude that TG1-catalysed cross-linking, regulated by TIG3, might play an important role in the formation of neuronal tau inclusions in certain tauopathies PMID: 22009441
    35. induction of TIG3 is associated with the suppression of anchorage-independent growth in certain aerodigestive tract cancer cells PMID: 12879006
    36. TIG3 facilitates the terminal stages in keratinocyte differentiation via activation of type I transglutaminase PMID: 12928434
    37. altered RARRES3 expression may play a role in the carcinogenesis of the liver and biliary tract. PMID: 15742394
    38. identification and characterization of the functional RA response element that is responsible for the RA-mediated induction of RIG1 gene PMID: 15850806
    39. TIG3 is negatively regulated by an activated MEK-ERK signaling pathway in ovarian carcinoma. PMID: 15856468
    40. The proapoptotic and anti-RAS activities of RIG1 are primarily associated with the Golgi localization of the protein. PMID: 17196792
    41. the TIG3 N-terminal region is required for TIG3-dependent keratinocyte differentiation, and its removal converts TIG3 into a proapoptotic protein PMID: 17762858
    42. The NC domain, especially the NC motif, plays the major role in RIG1-mediated pro-apoptotic activity. The RIG1(111-123) dodecapeptide exhibited strong pro-apoptotic activity and has potential as an anticancer drug. PMID: 19245694
    43. The tumor suppressors TIG3, HRASLS2 and H-rev107 are involved in the phospholipid metabolism with different physiological roles. PMID: 19615464

    顯示更多

    收起更多

  • 亞細(xì)胞定位：
    Membrane; Single-pass membrane protein.
  • 蛋白家族：
    H-rev107 family
  • 組織特異性：
    Widely expressed.
  • 數(shù)據(jù)庫(kù)鏈接：

    HGNC: 9869

    OMIM: 605092

    KEGG: hsa:5920

    STRING: 9606.ENSP00000255688

    UniGene: Hs.17466